INSERM;CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE BREST;UNIVERSITE DE BRETAGNE OCCIDENTALE - UBO
发明人:
RENAUDINEAU, YVES,MIGNEN, OLIVIER,BURGOS, MIGUEL,PERS, JACQUES OLIVIER,FALI, TINHINANE
申请号：
CA2952159
公开号：
CA2952159A1
申请日:
2015.07.31
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The invention relates to the use of the fraction of the STIM1 protein localized to the plasma membrane of the cells in a method for screening candidate molecules for treating chronic lymphatic leukaemia and/or systemic lupus erythematosus. The invention also relates to a substance interacting with the fraction of the STIM1 protein localized to the plasma membrane of the cells for use as a medicinal product in the treatment of chronic lymphatic leukaemia and/or systemic lupus erythematosus, as well as to a pharmaceutical composition comprising at least one substance according to the invention.
